Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$100K Buy
5,321
+151
+3% +$3.03K 0.05% 426
2026
Q2
$95.9K Sell
5,170
-1,919
-27% -$38.2K 0.04% 431
2026
Q1
$133K Hold
7,089
– – 0.04% 353
2025
Q4
$111K Buy
7,089
+1,546
+28% +$22.9K 0.03% 423
2025
Q3
$73.4K Buy
5,543
+2,083
+60% +$26.9K 0.02% 500
2025
Q2
$43K Buy
+3,460
New +$43.6K 0.02% 508

Other funds holding NOV

Essential Partners's NOV Position: Q3 2026 in Review

Essential Partners increased its NOV (NOV) stake by 2.9% in Q3 2026, buying an estimated $3.03K and bringing the position to 5,321 shares worth $100K. The position accounts for 0.05% of the portfolio, ranked #426.

Essential Partners first reported a position in NOV in Q2 2025 and has held it in 6 quarters since. The position peaked at $133K in Q1 2026. 81 funds tracked by Wall St. Rank hold NOV as of Q3 2026.

  • Essential Partners held 5,321 shares of NOV worth $100K as of Q3 2026.
  • Essential Partners bought 151 NOV shares in Q3 2026, an estimated $3.03K.
  • NOV made up 0.05% of Essential Partners's portfolio in Q3 2026, its #426 holding.
  • Essential Partners first reported a position in NOV in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's NOV position peaked at $133K in Q1 2026.
  • 81 funds tracked by Wall St. Rank held NOV as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.